Literature DB >> 29022777

Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.

Bo-Kyeong Kang1, Mimi Kim1, Soon-Young Song1, Dae Won Jun2, Kiseok Jang3.   

Abstract

OBJECTIVE: To assess the feasibility of proton density fat fraction (PDFF) MRI for estimating hepatic fat fraction with magnetic resonance spectroscopy (MRS) and histology as references and to investigate intrahepatic fat distribution and variability.
METHODS: Between November 2014 and September 2015, 85 adults (48 males, 47 females) who underwent MRI-PDFF (n = 139), MRS-PDFF (n = 49) and liver biopsy (n = 29) were enrolled in this study. Data were compared using linear regression. MRI-PDFF and standard deviations (variability) and differences between maximum and minimum PDFF (PDFF range) for whole liver, the lobes, and segment levels were calculated for each subject.
RESULTS: Whole-liver MRI-PDFF showed good correlation with MRS-PDFF (r = 0.961) and histologic degree of hepatic steatosis (σ = 0.809). Hepatic fat fraction is different between lobes and segments. Mean PDFF and mean PDFF range of the right lobe were higher than for the left lobe, whereas variability in the right lobe was lower than in the left lobe.
CONCLUSION: MRI-PDFF is an accurate non-invasive method for quantifying hepatic fat for various hepatic disorders, and may be preferable for measuring fat fraction in the right liver for more precise values in longitudinal monitoring, while avoiding FF measurement in the left liver. Advances in knowledge: MRI-PDFF provides a non-invasive and accurate quantification of hepatic steatosis in various hepatic disorders. It would be preferable to measure FF in the right liver than in the left liver.

Entities:  

Mesh:

Year:  2017        PMID: 29022777      PMCID: PMC6223148          DOI: 10.1259/bjr.20170378

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Nonalcoholic steatohepatits and liver steatosis modify partial hepatectomy recovery.

Authors:  Steffi Hoppe; Christian von Loeffelholz; Johan F Lock; Stephanie Doecke; Bruno V Sinn; Anja Rieger; Maciej Malinowski; Andreas F H Pfeiffer; Peter Neuhaus; Martin Stockmann
Journal:  J Invest Surg       Date:  2014-11-13       Impact factor: 2.533

3.  A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

Authors:  Ilkay S Idilman; Onur Keskin; Azim Celik; Berna Savas; Atilla Halil Elhan; Ramazan Idilman; Musturay Karcaaltincaba
Journal:  Acta Radiol       Date:  2015-04-08       Impact factor: 1.990

4.  Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.

Authors:  Bo-Kyeong Kang; Eun Sil Yu; Seung Soo Lee; Youngjoo Lee; Namkug Kim; Claude B Sirlin; Eun Yoon Cho; Suk Keu Yeom; Jae Ho Byun; Seong Ho Park; Moon-Gyu Lee
Journal:  Invest Radiol       Date:  2012-06       Impact factor: 6.016

5.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

6.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

7.  Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Authors:  Peter Bannas; Harald Kramer; Diego Hernando; Rashmi Agni; Ashley M Cunningham; Rakesh Mandal; Utaroh Motosugi; Samir D Sharma; Alejandro Munoz del Rio; Luis Fernandez; Scott B Reeder
Journal:  Hepatology       Date:  2015-09-28       Impact factor: 17.425

8.  Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management.

Authors:  A Y el-Hassan; E M Ibrahim; F A al-Mulhim; A A Nabhan; M Y Chammas
Journal:  Br J Radiol       Date:  1992-09       Impact factor: 3.039

9.  Fatty liver deposition and sparing: a pictorial review.

Authors:  Patrick-Olivier Décarie; Luigi Lepanto; Jean-Sébastien Billiard; Damien Olivié; Jessica Murphy-Lavallée; Claude Kauffmann; An Tang
Journal:  Insights Imaging       Date:  2011-06-28

Review 10.  Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.

Authors:  Sarit Anavi; Zecharia Madar; Oren Tirosh
Journal:  Redox Biol       Date:  2017-06-22       Impact factor: 11.799

View more
  7 in total

1.  The role of imaging in obesity special feature.

Authors:  Stuart A Taylor; Laura R Carucci
Journal:  Br J Radiol       Date:  2018-09       Impact factor: 3.039

2.  3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study.

Authors:  Fubi Hu; Ru Yang; Zixing Huang; Min Wang; Fang Yuan; Chunchao Xia; Yi Wei; Bin Song
Journal:  Quant Imaging Med Surg       Date:  2019-06

3.  Sample strategies for quantification of hepatic fat fraction mean MRI in healthy cats during body weight gain.

Authors:  Francesca Del Chicca; Henning Richter; Gian-Luca Steger; Elena Salesov; Claudia E Reusch; Patrick R Kircher
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

4.  Evaluation of a Whole-Liver Dixon-Based MRI Approach for Quantification of Liver Fat in Patients with Type 2 Diabetes Treated with Two Isocaloric Different Diets.

Authors:  Valentina Brancato; Giuseppe Della Pepa; Lutgarda Bozzetto; Marilena Vitale; Giovanni Annuzzi; Luca Basso; Carlo Cavaliere; Marco Salvatore; Angela Albarosa Rivellese; Serena Monti
Journal:  Diagnostics (Basel)       Date:  2022-02-16

5.  How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review.

Authors:  You-Wei Li; Yang Jiao; Na Chen; Qiang Gao; Yu-Kun Chen; Yuan-Fang Zhang; Qi-Ping Wen; Zong-Ming Zhang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

6.  Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.

Authors:  Qin-He Zhang; Ying Zhao; Shi-Feng Tian; Lu-Han Xie; Li-Hua Chen; An-Liang Chen; Nan Wang; Qing-Wei Song; Hao-Nan Zhang; Li-Zhi Xie; Zhi-Wei Shen; Ai-Lian Liu
Journal:  Quant Imaging Med Surg       Date:  2021-07

7.  Diagnostic Performance of Serum Asialo α1-Acid Glycoprotein Levels to Predict Liver Cirrhosis.

Authors:  Dae Hyun Lim; Mimi Kim; Dae Won Jun; Min Jung Kwak; Jai Hoon Yoon; Kang Nyeong Lee; Hang Lak Lee; Oh Young Lee; Byung Chul Yoon; Ho Soon Choi; Bo Kyeong Kang
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.